BamSEC and AlphaSense Join Forces
Learn More

Dianthus Therapeutics Inc. – Articles of Incorporation

NASDAQ: DNTH    
Share price (6/2/26): $81.57    
Market cap (6/2/26): $4.459 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-K 20 pages Third Amended and Restated By-Laws of Dianthus Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 6 pages Fifth Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56
EX-3.3
from S-4 14 pages By-Laws of Dianthus Therapeutics, Inc
12/34/56
EX-3.2
from S-4 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Dianthus Therapeutics, Inc
12/34/56
EX-3.1
from S-4 27 pages Amended and Restated Certificate of Incorporation of Dianthus Therapeutics, Inc
12/34/56
EX-3.1
from 8-A12B 8 pages Certificate of Designations of Series a Junior Participating Cumulative Preferred Stock of Magenta Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 23 pages Second Amended and Restated By-Laws of Magenta Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 23 pages Amended and Restated By-Laws of Magenta Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 7 pages Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 23 pages Amended and Restated By-Laws of Magenta Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 7 pages Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56
EX-3.3
from S-1 15 pages By-Laws of Magenta Therapeutics, Inc
12/34/56
EX-3.1
from S-1 25 pages Third Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56
EX-3.1
from DRS/A 25 pages Third Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56
EX-3
from DRS 25 pages Second Amended and Restated Certificate of Incorporation of Magenta Therapeutics, Inc
12/34/56